Cellino Biotech

This project by Cellino Biotech will use the company's proprietary NanoLaze gene-editing platform on the ground to deliver CRISPR/Cas9-modified genes to induced pluripotent stem cells (iPSCs) for growth studies in space. The research team will monitor the proliferation of the gene-edited iPSCs in space to determine if the cells maintain their pluripotentency through multiple cell divisions in micr...